Previsioni

Il prezzo obiettivo medio degli analisti è 4,09 € (+34,98%). La mediana è 4,09 € (+34,98%).

Acquista	6
Mantieni	3
Vendi	0

Notizie Vai al feed delle notizie

Sensus Healthcare: shareholders re-elect directors and ratify auditor

At Sensus Healthcare’s annual meeting, Eric Sachetta and Michael J. Sardano were re-elected as Class II directors for three-year terms. Shareholders also voted, in a non-binding advisory vote, to approve executive compensation for 2025 and ratified Carr, Riggs & Ingram as the independent auditor for fiscal year 2026. Sensus reported weak Q1 results with EPS of -$0.16 and revenue of $3.4 million, while the stock is trading near its 52-week low. » Altro su de.investing.com
Sensus Healthcare misses Q1 forecasts after sharp revenue decline

Sensus Healthcare reported Q1 2026 EPS of -$0.16 and revenue of $3.4 million, both below analyst expectations. Revenue fell 59% year over year, weighed down by missed sales to its largest customer and a shift to new business models. Adjusted revenue growth on a comparable basis was +26%. Management sees potential in new specific CPT codes and the Sensus Link software platform to improve reimbursement and drive future revenue growth. » Altro su de.investing.com
Acquisition leads to change of auditor at Sensus Healthcare

Sensus Healthcare dismissed Berkowitz Pollack Brant Advisors + CPAs (BPB) and appointed Carr, Riggs & Ingram (CRI) as its new independent auditor after CRI acquired certain assets of BPB’s capital markets business (effective Jan. 1, 2026). BPB’s audit report for the fiscal year ended Dec. 31, 2024, contained no disclaimers, modifications or disagreements with Sensus. The company also reported that a previously disclosed material IT-related control weakness had been remediated as of Dec. 31, 2024. In addition, Sensus reported revenue that exceeded expectations in the third quarter of 2025 and several board and management personnel changes, including the appointment of Larry Biscotti to the board of directors and the promotion of Michael Sardano to chief commercial officer. » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, SENSUS HEALTHCARE DL-,01 Aktie ha registrato ricavi pari a 2,01 Mln € e un utile netto di -7,67 Mln €

(EUR)	giu 2026	YoY
Ricavi	2,01 Mln	67,67%
Utile lordo	673,81K	72,64%
Utile netto	-7,67 Mln	771,32%
EBITDA	-2,71 Mln	99,46%

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	49,89 Mln €
Numero di azioni	16,46 Mln
Massimo/minimo a 52 settimane	4,73 € - 2,29 €
Dividendi	No
Beta	1,12
Rapporto P/E	-3,75
Rapporto PEG	0,04
Rapporto P/B	1,57
Rapporto P/S	3,31

Profilo aziendale

Sensus Healthcare, Inc. ist ein Medizintechnikunternehmen, das Geräte für die Strahlentherapie herstellt und an Gesundheitsdienstleister weltweit verkauft. Das Unternehmen verwendet in seinem Portfolio von Behandlungsgeräten die oberflächliche Strahlentherapie (SRT), eine Röntgentechnologie mit niedriger Energie. Das Unternehmen bietet das SRT-100 an, ein oberflächliches Röntgensystem mit niedriger Energie, das Patienten eine Alternative zur Operation bei der Behandlung von Nicht-Melanom-Hautkrebs, einschließlich Basalzell- und Plattenepithelkarzinomen, sowie anderen Hautkrankheiten, wie Keloiden, bietet. Das SRT-100 Vision bietet dem Anwender eine auf die SRT zugeschnittene Behandlungsplanungsanwendung, die das eingebettete Hochfrequenz-Ultraschall-Bildgebungsmodul, die volumetrische Tumoranalyse, die Planung von Strahlenrändern und Dosimetrieparameter integriert. Das Unternehmen bietet außerdem das SRT-100 Plus, das Sentinel-Serviceprogramm, das seinen Kunden Schutz für ihre Systeme bietet, und den Verleih von Lasern für die Praxis an. Darüber hinaus vertreibt das Unternehmen Einweg-Bleiabschirmungen und Einweg-Strahlenschutzartikel wie Schürzen und Augenschützer, Ultraschallsondenfolien und Einweg-Applikatorspitzen zur Behandlung von Läsionen unterschiedlicher Größe und verschiedener Körperregionen. Sensus Healthcare, Inc. wurde im Jahr 2010 gegründet und hat seinen Hauptsitz in Boca Raton, Florida.

Nome	SENSUS HEALTHCARE DL-,01 Aktie
CEO	Joseph C. Sardano
Sede centrale	Boca Raton, fl Stati Uniti
Sito web	sensushealthcare.com
Settore	Beni voluttuari
Industria	Beni durevoli per la casa
Quotazione in borsa	26/07/2016
Dipendenti	60